Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesM Alhenc-Gelas, G Plu-Bureau, S Guillonneau, et al.
Blood|August 15, 1997
The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic familiesM Alhenc-Gelas, V Le Cam-Duchez, J Emmerich, et al.
Thrombosis and Haemostasis|February 28, 1983
Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis)R Girot, F Jaubert, M Leon, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control studyJ L Reny, M Alhenc-Gelas, P Fontana, et al.
British Journal of Haematology|July 1, 1991
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VIS Gandrille, D Vidaud, J Emmerich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic riskM Aiach, V Nicaud, M Alhenc-Gelas, et al.
Annales De Biologie Clinique|January 1, 1985
[Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen]M Roncato, J F Vitoux, J M Pernes, et al.
British Journal of Haematology|October 16, 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutationV Le Cam-Duchez, S Gandrille, D Trégouët, et al.
Blood|July 1, 1995
Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERMS Gandrille, J S Greengard, M Alhenc-Gelas, et al.
Human Mutation|January 1, 1992
Two novel mutations responsible for hereditary type I protein C deficiency: characterization by denaturing gradient gel electrophoresisS Gandrille, M Vidaud, M Aiach, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesM Alhenc-Gelas, G Plu-Bureau, S Guillonneau, et al.
Blood|August 15, 1997
The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic familiesM Alhenc-Gelas, V Le Cam-Duchez, J Emmerich, et al.
Thrombosis and Haemostasis|February 28, 1983
Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis)R Girot, F Jaubert, M Leon, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control studyJ L Reny, M Alhenc-Gelas, P Fontana, et al.
British Journal of Haematology|July 1, 1991
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VIS Gandrille, D Vidaud, J Emmerich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic riskM Aiach, V Nicaud, M Alhenc-Gelas, et al.
Annales De Biologie Clinique|January 1, 1985
[Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen]M Roncato, J F Vitoux, J M Pernes, et al.
British Journal of Haematology|October 16, 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutationV Le Cam-Duchez, S Gandrille, D Trégouët, et al.
Blood|July 1, 1995
Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERMS Gandrille, J S Greengard, M Alhenc-Gelas, et al.
Human Mutation|January 1, 1992
Two novel mutations responsible for hereditary type I protein C deficiency: characterization by denaturing gradient gel electrophoresisS Gandrille, M Vidaud, M Aiach, et al.
Pageof 24